Loading...

PE/Cyanine7 anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_PECy7_083105
C57BL/6 splenocytes stained with 17A2 PE/Cyanine7
  • 17A2_PECy7_083105
    C57BL/6 splenocytes stained with 17A2 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100219 25 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100220 100 µg 199€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  2. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  3. Friesen M, et al. 2022. Brain Pathol. 32:e13032. PubMed
  4. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  5. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  6. Tran TA, et al. 2022. Front Immunol. 13:1007285. PubMed
  7. Lee CY, et al. 2022. J Invest Dermatol. :. PubMed
  8. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  9. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  10. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  11. Ryan CB, et al. 2022. Neurobiol Dis. 163:105608. PubMed
  12. Georgiev GI, et al. 2022. Cell Chem Biol. 29:811. PubMed
  13. Xiao R, et al. 2022. J Immunol. 208:2109. PubMed
  14. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  15. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  16. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  17. Sanmarco LM, et al. 2022. Nature. 611:801. PubMed
  18. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  19. Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed
  20. Sakae H, et al. 2023. Cells. 12:. PubMed
  21. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  22. Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed
  23. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  24. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  25. Nguyen T, et al. 2023. Nat Commun. 14:3357. PubMed
  26. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  27. Ho J, et al. 2016. PLoS Biol. 14:e2000117. PubMed
  28. Xiao C, et al. 2021. Front Pharmacol. 12:721273. PubMed
  29. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  30. d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
  31. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  32. Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
  33. Schneider C, et al. 2018. Cell. 174:271. PubMed
  34. Page N, et al. 2018. Immunity. 48:937. PubMed
  35. Vacca M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01462. PubMed
  36. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  37. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  38. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  39. Chen S, et al. 2022. Cancer Discov. :. PubMed
  40. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  41. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  42. De Vlaeminck Y, et al. 2020. Cancers (Basel). 12:. PubMed
  43. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  44. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  45. Feizi N, et al. 2021. Cell Death Dis. 12:1026. PubMed
  46. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  47. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  48. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  49. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  50. Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
  51. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  52. Patnode M, et al. 2013. J Biol Chem. 288:26533. PubMed
  53. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  54. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  55. Campana L, et al. 2018. J Immunol. 200:1169. PubMed
  56. Green CD et al. 2018. Developmental cell. 46(5):651-667 . PubMed
  57. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  58. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  59. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  60. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  61. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
  62. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
  63. Taube C, et al. 2011. PLoS One. 6:e21799. PubMed
  64. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  65. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  66. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  67. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  68. Wessel AW, et al. 2020. Nat Commun. 4.123611111. PubMed
  69. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  70. Ullah I, et al. 2021. Immunity. 54:2143. PubMed
  71. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  72. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  73. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  74. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  75. Kishore M et al. 2017. Immunity. 47(5):875-889 . PubMed
  76. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  77. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  78. De Veirman K, et al. 2021. Oncoimmunology. 10:2000699. PubMed
  79. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  80. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  81. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  82. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  83. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  84. Yazlovitskaya EM, et al. 2021. J Cell Sci. 134:. PubMed
  85. Yang R, et al. 2022. J Adv Res. 35:259. PubMed
  86. Song P, et al. 2018. Int J Mol Med. 41:935. PubMed
  87. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  88. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  89. M H, et al. 2016. Sci Rep. 6: 20588. PubMed
  90. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  91. Spix B, et al. 2022. Nat Commun. 13:318. PubMed
  92. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  93. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  94. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  95. Wieghofer P, et al. 2021. EMBO J. 40:e105123. PubMed
  96. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  97. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  98. Marcandalli J et al. 2019. Cell. 176(6):1420-1431 . PubMed
  99. Chen Z, et al. 2019. Mol Med Rep. 19:3210. PubMed
  100. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  101. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  102. Glasenapp A, et al. 2021. Circ Res. 129:369. PubMed
  103. Haase P, et al. 2020. Eur J Immunol. 50:558. PubMed
  104. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  105. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  106. Akoolo L, et al. 2021. Cell Microbiol. 23:e13350. PubMed
  107. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  108. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  109. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  110. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  111. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  112. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  113. Eastman AE, et al. 2020. Cell Rep. 31:107804. PubMed
  114. Reed-Geaghan EG, et al. 2020. J Exp Med. 217:00:00. PubMed
  115. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  116. Li H, et al. 2022. iScience. 25:104481. PubMed
  117. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  118. Carson W, et al. 2011. PLoS One. 6:e20385. PubMed
  119. Spevak CC, et al. 2020. Cell Stem Cell. 26(5):755-765. PubMed
  120. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  121. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  122. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
RRID
AB_1732068 (BioLegend Cat. No. 100219)
AB_1732057 (BioLegend Cat. No. 100220)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account